ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TRB Trinity Biotech Plc

0.00
0.00 (0.00%)
- - Realtime Data
Share Name Share Symbol Market Type
Trinity Biotech Plc TG:TRB Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Rule 8 - Tribal Group

27/06/2003 10:34am

UK Regulatory


RNS Number:8630M
Standard Life Investments
27 June 2003

                                                                    FORM 8.1/8.3



Lodge with a RIS or Newstrack if appropriate and the Takeover Panel.  Use a
separate form for each class of securities in which dealings have been made.



Date of Disclosure


27 Jun 2003



DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS
AND MERGERS



Date of dealing


26 Jun 2003



Dealing in (name of company)


Tribal Group



1. Class of securities (eg ordinary shares)


Ordinary GBP0.05



2.


Amount bought                      Amount sold              Price per unit - GBP
393,000                                                     3.1500000






3. Resultant total of the same class owned or controlled (and percentage of
class)


1,181,611.00                                         2.25%



4. Party making disclosure


Standard Life Investments




5. EITHER (a) Name of purchaser / vendor (Note 1)






OR (b) if dealing for discretionary client(s), name of fund management
organisation


Standard Life Investments



6. Reason for disclosure (Note 2)






(a) associate of



(i)  offeror (Note 3)



NO



(ii) offeree company



NO



Specify which category or categories of associate (1-8 overleaf)






If category (8), explain






(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the
class of relevant securities dealt in)



YES



Signed, for and on behalf of the party named in (4) above






(Also print name of signatory)


Graeme Brogan



Telephone and Extension number


0131 245 6826




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DCCEANKXADEDEEE

1 Year Trinity Biotech Chart

1 Year Trinity Biotech Chart

1 Month Trinity Biotech Chart

1 Month Trinity Biotech Chart

Your Recent History

Delayed Upgrade Clock